• 1
    van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR et al.Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116134.
  • 2
    Schoenwetter WF. Allergic rhinitis: epidemiology and natural history. Allergy Asthma Proc 2000;21:16.
  • 3
    Han DM, Zhang L, Huang D, Wu YF, Dong Z, Xu G et al.Self-reported prevalence of allergic rhinitis in eleven cities in China. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007;42:378384.
  • 4
    Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008;63(Suppl 86):8160.
  • 5
    Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005;60:350353.
  • 6
    Saleh HA, Durham SR. Perennial rhinitis. BMJ 2007;335:502507.
  • 7
    Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy 2007;62(Suppl 85):1725.
  • 8
    Petersen KD, Kronborg C, Gyrd-Hansen D, Dahl R, Larsen JN, Løwenstein H. Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires. Allergy 2008;63:284291.
  • 9
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl 5):S147S334.
  • 10
    Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2007;(1):CD001563.
  • 11
    Juniper EF, Stahl E, Doty RL, Simons FE, Allen DB, Howarth PH. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 2005;115(Suppl 1):S390S413.
  • 12
    Xue CC, Hűgel HM, Li CG, Story DF. Efficacy, chemistry and pharmacology of chinese herbal medicine for allergic rhinitis. Curr Med Chem 2004;11:14031421.
  • 13
    Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol 2007;99:483495.
  • 14
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:112.
  • 15
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557560.
  • 16
    Chui SH, Shek SL, Fong MY, Szeto YT, Chan K. A Panel Study to Evaluate Quality of Life Assessments in Patients Suffering from Allergic Rhinitis after Treatment with a Chinese Herbal Nasal Drop. Phytother Res 2010;24:609613.
  • 17
    Zhao Y, Woo KS, Ma KH, van Hansselt CA, Wong KC, Cheng KF et al.Treatment of perennial allergic rhinitis using Shi-Bi-Lin, a Chinese herbal formula. J Ethnopharmacol 2009;122:100105.
  • 18
    Yang SH, Yu CL. Antiinflammatory effects of Bu-zhong-yi-qi-tang in patients with perennial allergic rhinitis. J Ethnopharmacol 2008;115:104109.
  • 19
    Yang SH, Yu CL, Chen YL, Chiao SL, Chen ML. Traditional Chinese medicine, Xin-yi-san, reduces nasal symptoms of patients with perennial allergic rhinitis by its diverse immunomodulatory effects. Int Immunopharmacol 2010;10:951958.
  • 20
    Zhang H. Treatment of perennial allergic rhinitis 60 Cases by Bimin Decoction. J Tradit Chin Med 2004;45:4142.
  • 21
    Hu G, Walls RS, Bass D, Ramon B, Grayson D, Jones M et al.The Chinese herbal formulation biminne in management of perennial allergic rhinitis: a randomized, double-blind, placebo-controlled, 12-week clinical trial. Ann Allergy Asthma Immunol 2002;88:478487.
  • 22
    Jung JW, Kang HR, Ji GE, Park MS, Song WJ, Kim MH et al.Therapeutic effects of fermented red ginseng in allergic rhinitis: a randomized, double-blind, placebo-controlled study. Allergy Asthma Immunol Res 2011;3:103110.
  • 23
    Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ, Brzoza Z, Canonica GW et al.Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 2011;66:840844.
  • 24
    Yang SH, Hong CY, Yu CL. Decreased serum IgE level, decreased IFN-gamma and IL-5 but increased IL-10 production, and suppressed cyclooxygenase 2 mRNA expression in patients with perennial allergic rhinitis after treatment with a new mixed formula of Chinese herbs. Int Immunopharmacol 2001;1:11731182.
  • 25
    Yang SH, Hong CY, Yu CL. The stimulatory effects of nasal discharge from patients with perennial allergic rhinitis on normal human neutrophils are normalized after treatment with a new mixed formula of Chinese herbs. Int Immunopharmacol 2002;2:16271639.
  • 26
    Lenon GB, Li CG, Xue CC, Thien FC, Story DF. Inhibition of release of vasoactive and inflammatory mediators in airway and vascular tissues and macrophages by a chinese herbal medicine formula for allergic rhinitis. Evid Based Complement Alternat Med 2007;4:209217.
  • 27
    Lenon GB, Xue CC, Story DF, Thien FC, McPhee S, Li CG. Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis. Chin Med 2007;2:2.